Critical Care Medicine
Dr. Balu Bhaskar
Designation: Senior ICU consultant - Chief of Critical Care services
Specialty: Critical Care Medicine
Languages: English, Hindi/Urdu, Gujarati, Malayalam
- Management of advanced critically ill patients
- Core ICU procedures
- Advance airway management and Tracheostomy
- Advanced invasive haemodynamic monitoring
- Diagnostic and therapeutic Bronchoscopy
- Extra corporeal membrane oxygenator insertion and management
- Bedside Cardiac and lung ultrasound
- Anaesthesia for Bed side procedures both regional and general
- Advanced Burns Management
- Advanced Trauma Care
- Continuous renal replacement therapy
- BCLS, ACLS, PALS,FCCS,BASIC, ATLS
Dr Balu Bhaskar has an extensive experience in the field of Intensive Care Medicine. He has worked across Australia and UAE showcasing his clinical and teaching acumen. He graduated from India as a Cardiac Anaesthetist and completed his Critical care fellowship in Australia working in several recognised centres of excellence. He has extensive experience of more than 15 years in extra corporeal life support including Extracorporeal Membrane Oxygenation (ECMO). He also holds a Diploma in cardiac ultrasound and currently completing his Masters in hospital administration with Monash university, Australia.
Apart from being attached with hospitals as a senior ICU consultant, He is also an Adjunct Professor, a Reviewer of Peer Review Journals and has held several leadership roles. His teaching experience too spans across the globe, and he has been associated with various Universities and takes part in many prestigious courses as an organiser and tutor all over the world.
- FCICM-Fellow of College of Intensive Care Medicine, Australia
- Dip CU-Diploma in Cardiac Ultrasonography, Melbourne University
- ECMO Diploma-La Pitié International Diploma in ECMO & Temporary Respiratory/Circulatory Support
- FCCP-Fellow College of Chest Physicians, USA
- FCICM-Fellow of Joint Faculty of Intensive Care Medicine, Australia and New Zealand
- MD – Master of Medicine, Anaesthesiology, Saurashtra University, India
- MBBS – Calicut University, India
- College of Intensive Care medicine, Australia and New Zealand
- American College of Chest Physicians
Research & Publications
- Bhaskar B, Zeigenfuss M, Choudhary J, Fraser JF.Use of recombinant activated Factor VII for refractory after lung transplant bleeding as an effective strategy to restrict blood transfusion and associated complications.Transfusion. 2012 Jul 31
- Bhaskar B, Dulhunty J, Mullany DV, Fraser JF.Impact of blood product transfusion on short and long-term survival after cardiac surgery: more evidence.Ann Thorac Surg. 2012 Aug;94(2):460-7.
- Bhaskar B, Andelkovic V Foreign body aspiration pneumonia in an intravenous drug user.Saudi J Anaesth. 2012 Jan;6(1):65-8.
- Bhaskar B, Fraser JF.Negative pressure pulmonary edema revisited: Pathophysiology and review of management.Saudi J Anaesth. 2011 Jul; 5(3):308-13.
- Bhaskar B, Fraser JF, Mullany D.Lest we forget: heparin-induced hyperkalemia.J Cardiothorac Vasc Anesth. 2012 Feb; 26(1):106-9.
- Bhaskar B, Bidstrup BP, Fung YL, Fraser JF To transfuse, or not to transfuse that is the question.Crit Care Resusc. 2009 Mar;11(1):71-7. Review.
- ANZIC Influenza Investigators, Webb SA, Aubron C, Bailey M, Bellomo R, Howe B, McArthur C, Morrison S, Seppelt I.Critical care services and the H1N1 (2009) influenza epidemic in Australia and New Zealand in 2010: the impact of the second winter epidemic.Crit Care. 2011 Jun 9;15(3):R143.
- Bhaskar B, Jack RK, Mullany D, Fraser J.Comparison of outcome in Jehovah’s Witness patients in cardiac surgery: an Australian experience.Heart Lung Circ. 2010 Nov; 19(11):655-9.
- Ravi C Pillai,Fraser J,Bhaskar B. The Influence of Circulating Levels of Fibrinogen and Perioperative Coagulation Parameters on Predicting Postoperative Blood Loss in Cardiac Surgery: A Prospective Observational Study
- Bhaskar B, Mullany D, Shekar K Successful conservative management of an iatrogenic ECMO cannula related inferior vena cava injury. Anaesth Intensive Care. 2015 May; 43(3):418-9.
- Divithotawela C, Garrett P, Westall G, Bhaskar B, Tol M, Chambers DC. Successful treatment of cytomegalovirus associated hemophagocytic lymphohistiocytosis with the interleukin 1 inhibitor – anakinra.Respirol Case Rep. 2015 Nov 30;4(1):4-6. doi: 10.1002/rcr2.137. eCollection 2016 Mar.
- Khanna Ak, Jagiasi Bg, Bhaskar B. Consensus Statement for Pharmacological Management of Coronavirus Disease 2019 (COVID-19): A Pragmatic Approach, Asp Biomed Clin Case Rep. 2020 Dec 22;3(3):241-56
Number of Years of Experience: 25 years